Last update 01 Nov 2024
PharmaDax Inc.

PharmaDax Inc.

Private Company|
2008|
Taiwan Province, China
|
250-500
| ROCO: 4191|
www.pharmadax.com

Overview

Tags

Other Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
no Data
No Data
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
5-HT2A receptor x D2 receptor1

Related

2
Drugs associated with PharmaDax Inc.
Quetiapine Fumarate
Target
5-HT2A receptor x D2 receptor
Mechanism
5-HT2A receptor antagonists [+1]
Active Org.
Kyowa Pharmaceutical Industry Co., Ltd.Kyowa Pharmaceutical Industry Co., Ltd. [+10]
Originator Org.
AstraZeneca Pharmaceuticals Co. Ltd.AstraZeneca Pharmaceuticals Co. Ltd.
Active Indication
Bipolar and Related Disorders [+6]
Inactive Indication
Acute schizophrenia [+19]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date26 Sep 1997
GL-101
Target-
Mechanism-
Active Org.-
Originator Org.
Gliacure, Inc.Gliacure, Inc.
Active Indication-
Inactive Indication
Corneal Diseases [+4]
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with PharmaDax Inc.
NCT04884217 / Unknown statusPhase 2
Treatment of Dry Eye Disease Using Pro-ocular™ - A Proof of Concept, Safety, and Efficacy Study
100 Clinical Results associated with PharmaDax Inc.
Login to view more data
0 Patents (Medical) associated with PharmaDax Inc.
Login to view more data
100 Deals associated with PharmaDax Inc.
Login to view more data
100 Translational Medicine associated with PharmaDax Inc.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 25 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
1
1
Other
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Quetiapine Fumarate
 ( 5-HT2A receptor x D2 receptor )		Bipolar II disorder
More
Approved
GL-101
Kerato conjunctivitis sicca
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free